Fierce Biotech Names Character Biosciences a “Fierce 15” Biotech Company of 2025

JERSEY CITY, N.J.--(BUSINESS WIRE)--Character Biosciences, a precision medicine company transforming drug development for polygenic diseases, today announced that Fierce Biotech has named it as one of 2025’s “Fierce 15” biotechnology companies. The annual special report features the most innovative and promising private biotechnology companies in the industry. “Being named to the Fierce 15 is a recognition of the bold science our team is advancing to change the course of age-related eye disease